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Ascorbic acid in bronchial asthma
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Summary
Sixteen White children with bronchial asthma were
divided into two groups; one received standard anti-
asthma chemoprophylaxis (SAC) and the other
SAC supplemented with 1 g ascorbic acid (Redoxon)
given as a single daily dose for a 6-month period. In
10 patients the effects of ascorbic acid on exercise-
induced bronchoconstriction (EIS) were assessed
by comparing the pre-ascorbic acid results with
those obtained 21/ 2 hours after the intravenous
injection of 1 g ascorbic acid. Immunological inves-
tigations performed on the two groups were
assessment of polymorphonuclear leucocyte
(PMNL) motility, phagocytosis and nitroblue
tetrazolium reduction and measurement of secre-
tory IgA, serum immunoglobulin and-total haemo-
lytic complement levels and levels of the compo-
nents C3 and C4, lr,-antitrypsin, antistreptolysin 0
(ASO), C-reactive protein and antibodies to certain
respiratory viruses. These investigations were per-
formed before and 1, 3 and 6 months after the com-
mencement of therapy. Radio-allergosorbent test-
ing for sensitivity to four common allergens was
carried out at the outset and after 6 months of ther-
apy. Injection of ascorbic acid had no detectable
effects on the degree of EIS. Slight but not signifi-
cant immunological changes were observed in the
SAC group over the 6-month study period. How-
ever, in the SAC plus ascorbic acid group signifi-
cantly improved PMNL motility and decreased ASO
levels and reduced (although not to a significant
extent) IgE levels and titres of antibodies to the
respiratory viruses were observed.
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In a previous srudyl we observed that in a group of 10 children
receiving standard anti-asthma chemoprophylaxis (SAC) sup-
plemented with I g ascorbic acid daily both humoral and cellular
immune reactivity improved. However, since no control group
was included (i.e. on SAC only) the improvements in immuno-
logical function could not be attributed to SAC or ascorbic acid
alone or to a synergistic effect of both. In this investigation we
have assessed the effects of SAC only and SAC plus ascorbic acid
on certain cellular and humoral immune functions in a group of
children with bronchial asthma.
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Patients and methods
Twelve boys and 4 girls (average age 9,5 years) were investigated.
Informed parental consent was obtained in all cases. The child-
ren had all been referred to the Paediatric Respiratory Clinic at
the H. F. Verwoerd Hospital, Pretoria, for investigation and
management of asthma which had been difficult to control.
Patient were randomly selected on the basi of a history of
recurrent respiratory infections and asthma confirmed by lung
function studies.
All the patients had perennial asthma. Ten (7 boys and 3 girls)
had moderate asthma with an average resting maximal mid-
expiratory flow rate (MMEFR) of 66% of normal. Six (5 boys
and I girl) had more severe asthma with an average MMEFR of
36% of normal.
Patients were graded according to the history and the treat-
ment required to keep them in reasonable health. This correlated
\,·ell with the lung function findings.
All patients received 3 daily doses of sodium cromoglycate
(Lomudal) and either fenoterol (Berotec) or salbutamol (Ven-
tolin). Those with more severe asthma also received daily amino-
phylline. Patients were randomly assigned to two groups. Group
1(4 moderate and 3 severe asthmatics) received I g ascorbic acid
(Redoxon) as a single dose each morning in addition to the
standard therapy. Group 2 (6 moderate and 3 evere asthmatics)
received only standard therapy (Table I). No patients received
glucocorticoids before or during the study and none required
hospitalization for asthma during the course of the trial. Stool
examinations revealed no parasites. During the trial none of the
patients moved to a different environment and no change in
allergen avoidance procedures was instituted.
Lung function testing
All the children had a typically obstructive resting flow
volume curve with an MMEFR of less than 75% of the expected
normal value (average value 53%). All had exercise-induced
bronchoconstriction on treadmill testing performed according to
the standard method described by Silverman and Anderson. 2 A
fall in the peak expiratory flow rate (PEFR) and an MMEFR of
more than 15% of the resting value was considered significant.
Our patients had an average fall in MMEFR to 46% of the resting
values.
The effect of ascorbic acid on exercise-induced bronchocon-
striction was studied in the first 10 patients. An exercise study
was performed at 08hOO. Ascorbic acid (I g) was then adminis-
tered intravenously, and the patient rested for 21/, hours. The
exercise srudy was then repeated and compared with the original
study. Two patients improved slightly, 2 deteriorated slightly
and in 6 the differences between the two studies were not signifi-
cant. No beneficial or detrimental effect of ascorbic acid on
exercise bronchoconstriction could be demonstrated.
Polymorphonuclear leucocyte (P MNL)
functions
PMNLs were obtained from heparinized venous blood and
resuspended in Hanks's balanced salt solution as previously
describ.ed. 1 Investigations of P MNL motility, phagocytosis and
nitroblue tetrazolium (NBT) reduction were performed using
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Calculation and expression of results
Results are expressed as mean ± SE for each investigation"for
both groups. Statistical analyses were performed by Student's I
test (paired I statistic).
Effects of therapy on serological components
Insignificant decreases in serum levels of IgG, IgA and IgM
and secretory IgA were observed in both groups. Levels of total
haemolytic complement, C3, C4 and AAT were normal at the
outset and remained unchanged in both groups. CRP was not
detectable in the serum of any patient at any time (results not
well-documented techniques and the results of motility studies
expressed as PMNLs per high-power microscopic field
(cells/HPF).
Results
Initial clinical and laboratory findings (Table I)
Patients 1-9 received SAC only and patients 10-16 SAC plus
ascorbic acid. Of ~he 9 patients in the SAC group, 1 had low
PM L motility, 3 elevated levels of AS 0 and 4 elevated titres of
antibodies to the respiratory viruses. Of the 7 who received SAC
plus ascorbic acid, 2 had reduced PMN L motility and 4 elevated
ASO levels; tests for antibodies to the respiratory viruses were
positive in 4.
Effects of therapy on PMNL functions
No abnormalities ofPMNL phagocytosis of Candida albicans
or ofspontaneous and stimulated NBT reduction were observed
in any patient on initial investigation, and these findings were not
affected by either of the regimens (results not shown). PMNL
motility showed a light improvement in the SAC group, and in
the patient with reduced migration motility returned to normal.
Significant sustained stimulation ofPM L motility was observed
in the group receiving SAC plus ascorbic acid. These results with
autologous endotoxin-activated serum as the leuco-attractant are
shown in Table 11.
Serological tests
Serum IgG, IgA (as well as secretory IgA) and IgM levels,
total haemolytic complement activity and levels of C3 and C4,
C-reactive protein (CRP), ai-antitrypsin (AAT) and antibodies
to streptolysin 0 (ASO) were quantitated as previously des-
cribed. 1 Serum IgE levels were quantitated by the Phadebas IgE
PRIST test (Pharmacia) and values of ::::: 100 IV/ml were
considered to be elevated. Antibodies to the respiratory viruses
influenza A, Band C para-influenza 1, 2 and 3, respiratory
syncytial virus and adenovirus as well as to MycoplasmG pnelllllo-
niae were measured using a complement fixation test. Levels of
specific IgE against the common allergens Cynodon daccylon
(grass), DenllalOphagoides pleronyssimlls (mite), house dust and
cat epithelium were measured by the radio-aller-gosorbent test
(RAST) and results expressed according to extent of positivity
on the scale 0-4.
Serum a corbate levels were measured by the 2,4-dinirro-
phenylhydrazine method. J
These tests were performed before therapy and I, 3 and 6
months thereafter, with the exception of the RAST, which was
performed at the outset and at 6 months only. Only the clinician
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TABLE 11. EFFECTS OF SAC WITH AND WITHOUT
ASCORBIC ACID ON PMNL MIGRATION TO EAS·
Time of testing SAC only SAC + ascorbic acid
Before therapy 215 ± 18 229 ± 29
After 1 moo 267 ± 46 293 ± 19t
After 3 moo 185 ± 27 265 ± 31
After 6 moo 230 ± 20 303 ± 44t
'Results expressed as cells/HPF (mean:!: SE).
tP < 0,05.
shown). The effects of therapy on serum levels of IgE and ASO
are shown in Table Ill. Treatment with SAC and ascorbic acid
was associated with a significant reduction in ASO levels and
insignificant decreases in IgE levels. SAC alone was associated
with reduced ASO levels and slightly increased IgE levels, but
these changes were not significant. In the SAC and SAC plus
ascorbic acid groups there were totals of 17 and 15 positive titres
to the various respiratory viruses, which decreased to 12 and 9
respectively after 6 months of therapy, representing decreases of
30% and 40% respectively.
Serum ascorbic acid levels
Intravenous injection of 1 g ascorbic acid elevated the serum
ascorbic acid concentrations to > 40 ilg/ml 2 1/, hours after
injection. Ingestion of ascorbic acid increased the-mean serum
concentration from 10,8 ± 1,3 ilg/ml to 24,1 ± 2,4 ilg/ml.
Patients
No patient in either group experienced a severe attack of
asthma during the investigation or had an episode of serious
lower respiratory infection. All patients in both groups (with the
exception of patient 7, who required inhalant corticosteroids to
achieve adequate control) showed improved lung function as
determined on optimal therapy by a return to normal PEFR and
a rise in MMEFR to greater than 85% of the expected normal
value. There were no obvious differences between the two
groups.
Discussion
I t has been reported that in adult volunteers bronchoconstriction
caused by inhalation of histamine aerosols 4 and textile dusts; was
significantly reduced by prior administration ofO,5 - 1g ascorbic
acid and that this may relate to the antihistaminic activity of the
vitamin. 6 However, other investigators were unable to detect any
protective effects of ascorbic acid on the intensity of allergen- or
histamine-induced bronchoconstriction in mild asthmatics. 7
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Recently Anah et aP have reported that ingestion of ascorbic
acid by children with bronchial asthma in whom the attacks were
precipitated by virus infections decreased the frequency and
severity of asthmatic episodes. The trial was performed on a
double-blind basis over a 14-week period. Withdrawal of ascor-
bic acid was associated with an increase in the frequency of
attacks.
We have previously reported that SAC supplemented with I g
ascorbic acid daily for 6 month in a group of children with
bronchial asthma was associated with improved lung function
and immune reactivity. 1 However, the study was uncontrolled
and definite conclusions could not be drawn. In the present study
we have shown mat ascorbic acid per se has no protective effect
against exercise-induced bronchoconstriction. This was shown
in the group of 10 patients who received intravenous injections of
ascorbic acid to obtain high serum ascorbic acid levels and were
then tested for exercise-induced bronchospasm, and also by
comparing the effects of SAC with and without ascorbic acid
over an extended period.
However, significant differences were observed between the
two groups when PMNL motility, ASO levels and serum IgE
levels were investigated. Ascorbic acid supplementation was
associated with significantly improved PMNL motility and
decreased ASO levels. There wa also a drop in serum IgE levels,
but this was not significant. Improvements (although not signifi-
cant) were noted in PMNL motility and ASO levels in the
control group (no ascorbic acid), indicating that the effects in the
group receiving SAC plus ascorbic acid are probably synergistic.
Obviously a third group of patients receiving ascorbate only (i.e.
no SAC) would have been of interest. However, in view of our
findings that ascorbic acid alone conferred no protection against
exercise-induced bronchoconstriction the inclusion of such a
group could not be considered.
In view of these findings it is our opinion that ascorbic acid
may be a useful supplement to SAC in some patients with
bronchial asthma to confer a measure of protection against the
acquired transient defects ofPMNL migration and Iymphocyte
responsiveness to antigens which are often associated with ele-
vated IgE levels. 9 The raised ASO levels observed in patients
with bronchial asthma confirm our previous observation of this
association. 1 However, it is not yet known whether infections
withScreplOCOCCl/S pyogenes are the cause or the consequence (as a
result of atopy-associated decreased immunity) of some cases of
bronchial asthma. The high incidence of positive antibody titres
to the. respiratory viruses also indicates decreased immunity,
which may be primary (as a result of production ofvirus-specific
IgE'O) or secondary. Interestingly, the two regimens produced a
similar drop in these titres, indicating that SAC has an enhancing
effect on local immunity to the respiratory viruses.
The authors acknowledge the kind co-operalion of the staff of the
Virology Section, Departments of Medical Microbiology and Chem-
ical Palhology, InstitUle of Pathology, University of Pretoria, in
TABLE Ill. THE EFFECTS OF SAC WITH AND WITHOUT ASCORBIC
ACID ON SERUM LEVELS OF IgE· AND ASOt





















'Results expressed as IU/ml serum (mean ± SE).
t Results expressed as Todd units (mean ± SE).
:P < 0,025.
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measuring antiviral antibody titres and serum immunoglobulin and
ai-antitrypsin levels respectively.
REFERENCES
I. Anderson R, Hay I, Van Wyk H, Oosthuizen R, Theron A. The effect of
ascorbate on cellular humoral immunity in asthmatic children. S Afr Med J
1980; 58: 974-977.
2. Silverman j\1, Anderson SD. Standardization of exercise tests in asthmatic
children. Arch Dis Child 1972; 47: 882-889.
3. Anwood EC, Robey ED, Ross J, Bradley F, Kramer JJ. Determination of
platelet and leucocyte "itamin C and the I"'els found in normal subjects. Clin
Chilli Acta 1974; 54: 95-105.
4. Zmkin E, Lewis Aj, Bouhuys A. Inhibition of histamine induced airway
constriction by ascorbic acid.] AllerJ<v CIiI1/1II11111110/1973; 51: 218-226.
5. Zuskin E, Valic F, Bouhuys A. Byssinosis andairway responses due toexposure
to textile dust. LlIng 1976; 154: 17-23.
6. Subramanian N, Nandi BK, Majumder AK, Charrerjee lE. Role ofL-ascorbic
acid on detoxification of histamine. Biochem Pharmacol 1973; 22: 1671-1673.
7. Kreisman H, Mitchell C, Bouhuys A. Inhibition of histamine-induced airway
constriction: negative results with oxrriphyline and ascorbie acid. LlIng 1977;
154: 223-228.
8. Anah CO, Jarike LN, Baig HA. High dose ascorbic acid in Nigerian asthmatics.
Trop Geogr Med 1980; 32: 132-137.
9. Hill HR, Quie PG. Defective neutrophil chemotaxis associated with
hyperi=unoglobulinemia E. In: Bellanti JA, Dayton DH, cds. The
Phagocyr;c Cell in Hosr Resisrance. rew York: Raven Press, 1975: 249-266.
10. Welliver RC, Wong DT, Sun M, Middleton E, Vaughan RS, Ogra PLo The
development of respiratory syncytial virus-specific IgE and the release of
histamine in nasopharyngeal secretions after infection.NEnglJ Med 1981; JJ5:
841-846.
and health service







A community survey was undertaken in a district in
Kwazulu, adjacent to Pietermaritzburg, Natal, in
order to determine health status and health service
utilization patterns at a local level. This low-cost
survey was labour-efficient and yielded useful data
for the evaluation and planning of local health
services.
It was found fhat child health and delivery servi-
ces were under-utilized while family planning and
antenatal care services were .comparatively well
used. 'Traditional' practitioners' services were used
regularly by·51% of the mothers and childminders
interviewed. The use of the services of general med-
ical practitioners was less significant. Some 36% of
the children under 5 years of age were found to be
malnourished, and 29% had conditions requiring
medical treatment.
The findings of this study indicate that a major
discrepancy exists between the local need for health
services and utilization of the available services. The
introduction of community health workers is pro-
posed as a possible solution.
S AIr Med J 1983; 63: 652-655.
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Surveillance of the causes of morbidity and mortality is deve-
loped to a sophisticated degree at national and regional levels in
South Africa, but very little information is available at local
community level. This information is vital for health service
planners in the implementation of locally appropriate and effec-
tive health services. During the last decade the importance of
community surveys for the assessment of health status, attitudes
towards health care and the utilization ofhealth services has been
increasingly recognized world-wide. t
The purpose of this study was to obtain such information as
part of an evaluation of the health services offered by the Eden-
dale Hospital health ward. An attempt was also made to examirie
the possible role of 'village' or 'community health' workers in
this area in extending health services, as resources allocated for
health care in the homelands are very limited.
The study area
Vulindlela, one of the 5 magisterial districts in the Edendale
Hospital health ward, was chosen as the study area. It is part of
Kwazulu and is best described as a rural, peri-urban area,
spreading 15-40 km west ofPietermaritzburg, Natal, along the
road to Bulwer. The Black population ofVulindlela was 169070
- according to the 1980 census. 2 Ngubeni, a village of approxi-
mately 110 households, was selected as it appeared to be repre-
sentative of the other villages in Vulindlela in terms of size,
infrastructure and socio-economic conditions, Concurrently, a
large community survey was conducted by the Development
Studies Research Group of the University of Natal, Durban. 3 A
comparison of the results from these two surveys confirmed that
Ngubeni was representative of the rest of Vulindlela.
